Back to Search
COLLEEN SHIPMAN, PHARMD
PHARMD
Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist
NPI: 1588384101Individual
Specialties, Licenses & Credentials
Pharmacist Clinician (PhC)/ Clinical Pharmacy SpecialistPrimary
Pharmacist — Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist
Code: 1835P0018X
0011438(OR)
Research & Publications (20)
Osteoprotegerin is a soluble decoy receptor for tumor necrosis factor-related apoptosis-inducing ligand/Apo2 ligand and can function as a paracrine survival factor for human myeloma cells.
PMID 12615702·Cancer Res·2003
8-other
Access to care in advanced COPD: factors that influence contact with general practice services.
PMID 19333517·Prim Care Respir J·2009
8-other
The views of patients with advanced cancer regarding participation in serial questionnaire studies.
PMID 18838489·Palliat Med·2008
8-other
Improving generalist end of life care: national consultation with practitioners, commissioners, academics, and service user groups.
PMID 18829640·BMJ·2008
4-observational
Improving district nurses' confidence and knowledge in the principles and practice of palliative care.
PMID 18727752·J Adv Nurs·2008
8-other
Is the qualitative research interview an acceptable medium for research with palliative care patients and carers?
PMID 18435846·BMC Med Ethics·2008
8-other
Nursing the dying within a generalist caseload: a focus group study of district nurses.
PMID 18313675·Int J Nurs Stud·2008
8-other
"I will do it if it will help others:" motivations among patients taking part in qualitative studies in palliative care.
PMID 18243642·J Pain Symptom Manage·2008
8-other
Roles, service knowledge and priorities in the provision of palliative care: a postal survey of London GPs.
PMID 16903401·Palliat Med·2006
8-other
LIGHT (TNFSF14), a novel mediator of bone resorption, is elevated in rheumatoid arthritis.
PMID 16649193·Arthritis Rheum·2006
7-preclinical
Selective inhibition of Rab prenylation by a phosphonocarboxylate analogue of risedronate induces apoptosis, but not S-phase arrest, in human myeloma cells.
PMID 16619218·Int J Cancer·2006
8-other
Advances in the management of myeloma bone disease.
PMID 16318429·Expert Opin Pharmacother·2005
6-review
Palliative care services in England: a survey of district nurses' views.
PMID 16116400·Br J Community Nurs·2005
8-other
Continuity within primary palliative care: an audit of general practice out-of-hours co-operatives.
PMID 15454596·J Public Health (Oxf)·2004
8-other
Building bridges in palliative care: evaluating a GP Facilitator programme.
PMID 14594154·Palliat Med·2003
8-other
Zoledronic acid treatment of 5T2MM-bearing mice inhibits the development of myeloma bone disease: evidence for decreased osteolysis, tumor burden and angiogenesis, and increased survival.
PMID 12619933·J Bone Miner Res·2003
7-preclinical
Bisphosphonates and osteoprotegerin as inhibitors of myeloma bone disease.
PMID 12548581·Cancer·2003
7-preclinical
Recombinant osteoprotegerin decreases tumor burden and increases survival in a murine model of multiple myeloma.
PMID 12543775·Cancer Res·2003
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3181 SW SAM JACKSON PARK RD
PORTLAND, OR 97239 - Phone
- (503) 494-8007
Quick Facts
- NPI
- 1588384101
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile